Aeon Biopharma Inc. has announced that Marc Forth is stepping down as chief executive and president, effective April 4.
The Irvine-based biopharmaceutical company appointed Jost Fischer, current chairman of the board, as interim CEO.
“On behalf of the Board, I want to thank Marc for his invaluable contributions to AEON over the last several years and his dedication to exhaustively evaluating all opportunities for the Company to execute its growth strategy,” Fischer said in a statement.
Aeon said that Forth was departing the company to “pursue another opportunity,” which wasn’t disclosed. Forth is expected to remain at the company as a member of the board of directors.
Shares in Aeon (NYSE: AEON) are down 7.3% to 59 cents and a $6.2 million market since the leadership transition was announced yesterday.
